Atlas Trials

A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients (FRESCO)

Clinical trial NCT02314819 · COMPLETED

Trial details

NCT number
NCT02314819
Sponsor
Hutchison Medipharma Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2014-12-01
Primary completion
2017-01-01
Enrollment
416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.